Drug Consulting Blueprint Network

Award Date 9/22/2014
Last Date To Order 9/27/2020
Shared Ceiling $6.3M
Contract Type
Master IDIQ
Predecessor
Not listed
Successors

The Drug Consulting Blueprint Network (IDIQ-NIH-DCBN) is a master indefinite delivery/indefinite quantity contract administered by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH). The contract vehicle supports drug development consulting services across various specialized domains, including medicinal chemistry, toxicology, bioactivity assay development, process chemistry, and nonclinical drug development. Task orders under this vehicle appear to target senior-level expertise in neuroscience and addiction research, covering exploratory through preclinical stages of drug discovery and development.

The task orders typically range from approximately $3,000 to $107,000, with most contracts lasting approximately one year and concluding on September 27th of their respective fiscal years. Frequent prime contractors include individual consultants and small consulting firms such as Graham Johnson, JM Sisco Pharma Consulting, WHM Consulting, JP Lawson Consulting, and Integrated Nonclinical Development Solutions. While most task orders were not set aside for specific business types, one task order to Donna L. Romero was designated as a Total Small Business set-aside. The majority of task orders are firm fixed-price or labor-hour contracts, supporting NIDA's mission of advancing drug development and addiction research through specialized consulting services.

Generated 1/16/25, 12:03 AM